cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Anak Agung Gde Putra Wiraguna
Contact Email
editor.balidv@gmail.com
Phone
+6282339990824
Journal Mail Official
editor.balidv@gmail.com
Editorial Address
Dermatology and Venereology Department, Medical Faculty, Universitas Udayana/Prof. dr. I G. N. G. Ngoerah General Hospital, 3rd Floor (Jl. Diponegoro, Dauh Puri Klod, Kecamatan Denpasar Barat, Kota Denpasar, Bali 80113)
Location
Kota denpasar,
Bali
INDONESIA
Bali Dermatology Venereology and Aesthetic Journal
Published by Universitas Udayana
ISSN : 30467985     EISSN : 30467993     DOI : https://doi.org/10.51559/balidervenaesthj.v6i1.33
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health
Bali Dermatology Venereology and Aesthetic Journal is an open access; peer-reviewed journal aiming to communicate high-quality research articles, reviews, and general articles in the Dermatology, Venereology and Aesthetic field. The Journal aims to bridge and integrate the intellectual, methodological, and substantive diversity of Dermatology, Venereology and Aesthetic and to encourage a vigorous dialogue between researcher, medical scholars and practitioners. The scope of this journal includes: General dermatology Venereology Cosmetic dermatology/aesthetic Pediatric dermatology Allergy and immunology Skin and tumor surgery Tropical dermatology Genodermatosis (hereditary skin disease) Travel dermatology Traditional, Complementary, and Integrative medicine in dermatology Diagnostic method and artificial intelligence in dermatology
Arjuna Subject : Kedokteran - Dematologi
Articles 5 Documents
 1 
Search results for , issue "BDVAJ - Volume 8, Issue 2 (2025)" : 5 Documents clear
Skin disorders that mimic melanoma: a review Citrashanty, Irmadita; Hendaria, Made Putri
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 8, Issue 2 (2025)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v8i2.114

Abstract

Malignant melanoma is a skin disorder that originates from the degeneration of melanocyte pigment cells towards malignancy, which is characterized by an increasingly enlarged and irregular and more prominent color change. Many skin disorders have similarities with malignant melanoma, which sometimes makes it difficult for medical personnel to make a diagnosis. Skin conditions that resemble melanoma are categorized into histogenetic lines such as melanocytic (Spitz naevus, Cellular blue naevus, melanocytic naevus with focal atypical epithelioid component/clonal naevus, Deep penetrating naevus), neural (Malignant peripheral nerve sheath tumor, Neurotheceomakell (Sicatrical). When the intraepidermal melanocytic component is subtle or missing, or the tumor displays uncommon histological features, misclassification of melanoma is more likely. The recent implementation of clearer clinical and histopathological criteria with the development of dermoscopy and computer technology has been able to led to the early detection of melanoma, which has contributed to the increased diagnosis of this disease and other skin diseases that may have similarities to melanoma. This review aimed to differentiate melanoma-like skin disorders.
Challenges of limited treatment options in suspected antimicrobial resistance of multibacillary Hansen's disease with chronic erythema nodosum leprosum: a case report and literature review Lukito, Agrevina Ane; Wibawa, I Ketut Suteja; Supradnyan, I Komang Harry
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 8, Issue 2 (2025)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v8i2.120

Abstract

Background: Hansen's disease, or leprosy, is a chronic infection caused by Mycobacterium leprae that affects the skin and peripheral nerves. The emergence of antimicrobial resistance in leprosy poses a new challenge, potentially reducing treatment efficacy and increasing the risk of relapse. Recent studies report recurrent or chronic erythema nodosum leprosum (ENL)  cases linked to relapse caused by drug-resistant Mycobacterium leprae strains. This case report aimed to emphasize the knowledge and therapeutic approach of leprosy and leprosy reaction. Case Description: A 51-year-old female patient previously treated for multibacillary (MB) leprosy and declared released from treatment (RFT) a year earlier, presented with painful erythematous nodules on all extremities two months after RFT. Eight months after RFT, the patient developed new erythematous macules with loss of sensation on all extremities, consistent with leprosy relapse. Multi-drug therapy (MDT) was subsequently re-initiated. During follow-up, laboratory evaluation indicated a high bacterial load, raising suspicion of antimicrobial resistance. The patient was initiated on the regimen for leprosy with antimicrobial resistance. However, the complete regimen could not be provided immediately due to medication limitations in the remote region. Conclusion: Antimicrobial resistance in leprosy should be considered in patients with relapse who do not respond to MDT re-treatment and in those with chronic ENL. Limited availability of resistance testing resources and access to second-line therapies remain a significant barrier to the effective management of antimicrobial resistance leprosy.
Profile of syphilis in pregnancy at the Dermatovenereology Clinic, Bali Mandara General Hospital (2020–2024) Trisnawati, Febri Evalina; Wahyuni, Luh Putu Dina
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 8, Issue 2 (2025)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v8i2.121

Abstract

Introduction: Syphilis is a chronic and systemic sexually transmitted infection (STI) caused by Treponema pallidum. There are four stages of syphilis based on clinical manifestations: primary, secondary, latent, and tertiary. This study aimed to obtain data on pregnant women diagnosed with syphilis and their characteristics at the Dermatovenereology Clinic of Bali Mandara General Hospital, Denpasar, from January 2020 to December 2024. Methods: This research utilized a retrospective descriptive design by collecting secondary data from the medical records of patients who visited the Dermatovenereology Clinic of Bali Mandara General Hospital, Denpasar, during the period of January 2020 to December 2024. Results: A total of 23 cases of syphilis in pregnancy were recorded between January 2020 and December 2024, distributed as follows: 2 cases in 2020 (8%), 1 case in 2021 (5%), 14 cases in 2023 (61%), and 6 cases in 2024 (26%). The majority of cases occurred in women aged 26–35 years (52%). Most patients (15 individuals) were in their third trimester of pregnancy, and late latent syphilis was the most common stage found (87%). Conclusion: Between 2020 and 2024, there were 23 cases of syphilis in pregnancy at Bali Mandara General Hospital, with most cases classified as late latent syphilis diagnosed in the third trimester.
Tinea incognito due to misuse of steroids and whitening body lotion: a case report Imaroh, Rifa; Lumaksono, Maria Angela; Hardiati, Rien; Imani, Izzah; Widasmara, Dhelya
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 8, Issue 2 (2025)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v8i2.122

Abstract

Background: Tinea incognito (TI) is a dermatophytic infection with atypical clinical manifestations resulting from inappropriate use of topical corticosteroids. The misuse of over-the-counter steroids and unregulated cosmetic products, such as whitening body lotions, can alter the classical presentation of dermatophytosis, leading to delayed diagnosis and treatment failure. This case report aims to highlight the clinical features of tinea incognito associated with topical steroid misuse and whitening body lotion application, emphasizing the importance of early recognition and appropriate management to prevent misdiagnosis and treatment delay. Case: A 29-year-old woman presented with persistent pruritic erythematous patches on her back that had progressively enlarged over two months. The lesions initially appeared as small erythematous patches and were treated with topical corticosteroids prescribed by non-physician health practitioners. The patient continued self-medication with freely purchased topical steroids without improvement. She subsequently applied a whitening body lotion in an attempt to resolve the lesions; however, the patches worsened and expanded. Physical examination of the thoracolumbosacral region revealed ill-defined erythematous plaques with multiple peripheral erythematous papules and fine scaling. Laboratory examinations were not performed. The diagnosis of tinea incognito was established based on clinical history and physical findings. Treatment consisted of oral ketoconazole 200 mg daily, topical ketoconazole 2% cream, ketoconazole 2% shampoo twice weekly, nonsteroidal moisturizer, and antihistamines for two weeks. The patient was advised to discontinue topical steroids and whitening body lotion and received education on clean and healthy living behaviors. Significant clinical improvement was observed during follow-up. Conclusion: Discontinuation of topical steroids and inappropriate cosmetic products, combined with appropriate antifungal therapy, resulted in favorable clinical outcomes. Improved regulation of steroid and cosmetic product distribution, along with increased awareness among healthcare providers, is essential to prevent misdiagnosis and the rising incidence of tinea incognito.
Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review Handayani, Theressia; Jawi, I Made
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 8, Issue 2 (2025)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v8i2.124

Abstract

Metabolic syndrome (MetS) is a constellation of metabolic abnormalities—including central obesity, dyslipidemia, hypertension, and impaired glucose regulation—that considerably increases cardiometabolic risk. Recent evidence emphasizes that MetS significantly influences the skin, which serves as a visible indicator of underlying metabolic dysfunction. The emerging concept of metabolic aging describes the acceleration of biological aging driven by chronic metabolic stress through mechanisms such as inflammaging, oxidative stress, mitochondrial dysfunction, microvascular injury, and the accumulation of advanced glycation end products (AGEs). Cutaneous signs associated with insulin resistance—including acanthosis nigricans, skin tags, acne in PCOS, hidradenitis suppurativa, and early-onset androgenetic alopecia (AGA)—are increasingly recognized as reliable clinical markers of metabolic dysregulation. Early-onset AGA has a strong epidemiological association with insulin resistance, dyslipidemia, and increased cardiometabolic risk. Understanding these links is essential for dermatologists and aesthetic practitioners, as metabolic dysfunction affects wound healing, treatment response, and procedural safety. This narrative review aims to summarize current evidence on the relationship between metabolic syndrome, metabolic aging, and cutaneous manifestations, with particular emphasis on clinically observable dermatologic markers of insulin resistance and their implications for dermatology and aesthetic practice.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue BDVAJ - Volume 8, Issue 2 (2025) BDVAJ - Volume 8, Issue 1 (2025) BDVAJ - Volume 7, Issue 2 (July 2024) BDVAJ - Volume 7, Issue 1 (January 2024) BDVAJ - Volume 6, Issue 2 (December 2023) BDVAJ - Volume 6, Issue 1 (June 2023) BDVJ - Vol. 5 No. 2 (December 2022) BDVJ - Vol. 5 No. 1 (June 2022) BDVJ - Vol. 4 No. 2 (December 2021) BDVJ - Vol. 4 No. 1 (June 2021) BDVJ - Vol. 3 No. 2 (December 2020) BDVJ - Vol. 3 No. 1 (June 2020) BDVJ - Vol. 2 No. 2 (December 2019) BDVJ - Vol. 2 No. 1 (June 2019) BDVJ - Vol. 1 No. 2 (December 2018) BDVJ - Vol. 1 No. 1 (June 2018) More Issue